FDA Inspection 892301 — Changzhou Qianhong Biopharma Co., Ltd.

Changzhou Qianhong Biopharma Co., Ltd. — FEI 3005275502

The FDA completed an inspection of Changzhou Qianhong Biopharma Co., Ltd. on August 1, 2014 in Changzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 1, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Changzhou (China)